Department of Microbiology, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Mobihealth International Limited, Abuja, Nigeria.
PLoS One. 2021 Nov 4;16(11):e0259398. doi: 10.1371/journal.pone.0259398. eCollection 2021.
The first case of COVID-19 in Nigeria was recorded on February 27, 2020, being an imported case by an Italian expatriate, to the country. Since then, there has been steady increase in the number of cases. However, the number of cases in Nigeria is low in comparison to cases reported by other countries with similar large populations, despite the poor health system prevailing in the country. This has been mainly attributed to the low testing capacity in Nigeria among other factors. Therefore, there is a need for innovative ways to increase the number of persons testing for COVID-19. The aim of the study was to pilot a nasopharyngeal swab self-sample collection model that would help increase COVID-19 testing while ensuring minimal person-to-person contact being experienced at the testing center. 216 participants took part in this study which was carried out at the Nigerian Institute of Medical Research between June and July 2020. Amongst the 216 participants, 174 tested negatives for both self-collected samples and samples collected by Professionals, 30 tested positive for both arms, with discrepancies occurring in 6 samples where the self-collected samples were positive while the ones collected by the professionals were negative. The same occurred in another set of 6 samples with the self-collected samples being negative and the professional-collected sample coming out positive, with a sensitivity of 83.3% and a specificity of 96.7%. The results of the interrater analysis are Kappa = 0.800 (95% CI, 0.690 to 0.910) which implies an outstanding agreement between the two COVID-19 sampling methods. Furthermore, since p< 0.001 Kappa (k) coefficient is statistically different from zero, our findings have shown that self-collected samples can be reliable in the diagnosis of COVID-19.
尼日利亚首例 COVID-19 病例于 2020 年 2 月 27 日记录,为一名意大利侨民输入病例。自那时以来,病例数量稳步增加。然而,与其他人口众多的国家报告的病例相比,尼日利亚的病例数量较低,尽管该国的卫生系统较差。这主要归因于尼日利亚检测能力低等因素。因此,需要创新的方法来增加进行 COVID-19 检测的人数。本研究的目的是试点一种鼻咽拭子自我采样收集模型,该模型将有助于增加 COVID-19 检测数量,同时确保在检测中心尽可能减少人与人之间的接触。2020 年 6 月至 7 月,216 名参与者参加了在尼日利亚医学研究所进行的这项研究。在 216 名参与者中,有 174 名自我采集样本和专业人员采集样本均为阴性,30 名两种采集方法均为阳性,6 份样本出现差异,其中自我采集样本阳性而专业采集样本为阴性。另一组 6 份样本的情况相同,自我采集样本为阴性,专业采集样本为阳性,敏感性为 83.3%,特异性为 96.7%。两次检测结果的 Kappa 值为 0.800(95%置信区间,0.690 至 0.910),表明两种 COVID-19 采样方法之间存在出色的一致性。此外,由于 p<0.001,Kappa(k)系数在统计学上与零不同,我们的研究结果表明,自我采集样本可用于 COVID-19 的诊断。